Big Investors Ask Drugmakers And Biotechs To Support Biosimilars
Published: Aug 12, 2014
A group of 19 institutional investors is asking the boards of more than two dozen drug makers and biotechs to agree to various business principles in hopes of supporting use of biosimilar medicines. As you may know, these are designed to emulate brand-name biologics and are forecast to save the U.S. economy valuable health care dollars once they become available.
Help employers find you! Check out all the jobs and post your resume.